Potent inducers of terminal differentiation and method of use thereof
AssigneeSloan-Kettering Institute for Cancer Research
InventorsRonald Breslow, Paul A. Marks, Richard A. Rifkind
Life of this patent
Estimating the term…
Loading patent…
AssigneeSloan-Kettering Institute for Cancer Research
InventorsRonald Breslow, Paul A. Marks, Richard A. Rifkind
Estimating the term…
This invention is directed to compounds having the structure: ##STR1## wherein R.sub.1 and R.sub.2 are independently the same as or different from each other; when R.sub.1 and R.sub.2 are the same, each is a substituted or unsubstituted arylamino, cycloalkylamino, pyridineamino, piperidino, 9-purine-6-amine or thiazoleamino group; when R.sub.1 and R.sub.2 are different, R.sub.1 =R.sub.3 --N--R.sub.4, and n is an integer from about 4 to about 8. This invention also provides a method of selectively inducing terminal differentiation of neoplastic cells and thereby inhibiting proliferation of such cells. The invention further provides pharmaceutical compositions comprising a therapeutically effective amount of the compounds of the present invention and a pharmaceutically acceptable carrier.
A compound having the structure:
A compound having the structure:
A compound having the structure:
A compound having the structure:
A compound having the structure:
Dependencies are inferred from the claim text.